The Problem: More than half of the new drugs or digital services launched by Life Sciences and Healthcare companies underperform in the markets due to poor patient identification for timely treatment options.
CapsicoHealth brings a market leading Gen-AI & LLM Platform and Agent Driven Workflows for Market Access, MSL, HEOR, Clinical Affairs stakeholders to get deep insight into targeted populations and treatment response.
Life Sciences and healthcare enterprises are challenged with analyzing billions of data points to generate insights, enable outcomes predictions and target populations for timely care.
Poor outcomes occur when patient pathways include suboptimal care and untimely treatments. Over 60% of patients do not see optimal treatment due to limited access.
Patient journeys are critical to driving insight into timely treatment and therapies, while ensuring outcomes improvement. The MSL co-pilot empowers medical science liasons, market access specialists and growth strategists on real-world insights on therapies.